The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma

Up to 20–40% of patients with Hodgkin's lymphoma will eventually relapse after treatment, among which early relapse confers a poor outcome. With salvage chemotherapy followed by autologous stem cell transplantation (ASCT), the long-term remission rate is 30%. We report our experience of using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangarsa, Eko A., Naibaho, Ridho M., Yunarvika, Vina, Setiawan, Budi, Santosa, Damai, Suharti, Catharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580659/
https://www.ncbi.nlm.nih.gov/pubmed/34777885
http://dx.doi.org/10.1155/2021/9632427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580659/
https://www.ncbi.nlm.nih.gov/pubmed/34777885
http://dx.doi.org/10.1155/2021/9632427

Ejemplares similares